Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
06/08/2026 21:16
BRIEF-X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million Aug 06 (Reuters) - X4 Pharmaceuticals Q2 income from operations USD -16.391 million.
- Q2 net income USD -16.157 million
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule